Ascletis Pharma Inc (2VJ) — Financial Flexibility Index
Ascletis Pharma Inc (2VJ) has a Financial Flexibility Index of -0.36x as of June 2023. Free cash flow of €-33.05 Million (operating CF €-33.98 Million minus capex €924.50K) represents 0% of total liabilities (€90.79 Million). Check 2VJ tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ascletis Pharma Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Ascletis Pharma Inc across 10 annual periods. For the full cash flow conversion analysis, see 2VJ cash generation efficiency.
Annual Financial Flexibility Index for Ascletis Pharma Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Ascletis Pharma Inc. Explore 2VJ operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.14x | €-414.80 Million | €-416.78 Million | €132.26 Million | ▼ -46.4% |
| 2024 | -2.14x | €-339.43 Million | €-341.58 Million | €158.41 Million | ▼ -56.0% |
| 2023 | -1.37x | €-204.64 Million | €-223.79 Million | €148.94 Million | ▼ -18.9% |
| 2022 | -1.16x | €-135.38 Million | €-142.45 Million | €117.16 Million | ▲ +17.9% |
| 2021 | -1.41x | €-141.96 Million | €-146.93 Million | €100.89 Million | ▼ -50.3% |
| 2020 | -0.94x | €-79.99 Million | €-84.91 Million | €85.42 Million | ▼ -72.5% |
| 2019 | -0.54x | €-55.46 Million | €-74.34 Million | €102.17 Million | ▲ +32.7% |
| 2018 | -0.81x | €-80.77 Million | €-96.59 Million | €100.19 Million | ▲ +46.4% |
| 2017 | -1.51x | €-182.76 Million | €-198.06 Million | €121.42 Million | ▼ -696.2% |
| 2016 | 0.25x | €32.11 Million | €-12.50 Million | €127.18 Million | — |